Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (177)
  • 2025 (50)

Subject

  • Drug Trafficking (1305)
  • Synthetic drugs (450)
  • Arrests/Convictions - Major (368)
  • Guns/Weapons (326)
  • Fake Pills (273)
  • OCDETF/Task Force (191)
  • Seizures (Drugs/Property) (191)
  • Guilty Plea (181)
  • Fentanyl Awareness (136)
  • Prescription Drugs (107)
  • Counterfeit Pills (104)
  • Task Forces/Task Force Officers (98)
  • Major Law Enforcement Operation (91)
  • Money Laundering (74)
  • Outreach/Drug Prevention (69)
  • Overdose (69)
  • Take Back Day (63)
  • One Pill Can Kill (55)
  • Gangs (53)
  • Pharmaceuticals/Pharmacists/Physicians (53)
  • HIDTA (32)
  • Campaigns (29)
  • Other (29)
  • Cartel (28)
  • Press Conferences (23)
  • Extraditions (22)
  • Narcoterrorism (22)
  • Prevention/Education - DEA websites GSAD, JTT etc (20)
  • Terrorism (11)
  • International/Foreign Operations (10)
  • Public and Media Affairs - also see Congressional Affairs (10)
  • Dark Web- Internet Trafficking (7)
  • Critical Incident (5)
  • Asset Forfeiture (4)
  • Intelligence Division - Intelligence Products (4)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Red Ribbon (2)
  • Forensics: Quality Management System Documents (1)
  • Fentanyl Free America (142)
  • Diversion Division (92)

Drug Name

  • Fentanyl (87)
  • Methamphetamine (27)
  • Cocaine (22)
  • Heroin (13)
  • Oxycodone (9)
  • Hydromorphone (6)
  • Benzodiazepines (5)
  • Marijuana (Cannabis) (5)
  • Amphetamines (4)
  • Ecstasy/MDMA (2)
  • Opioids (2)
  • Synthetic Opioids (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Morphine (1)
  • Xylazine (1)

Field Division

  • Atlanta (4)
  • Caribe (1)
  • Chicago (4)
  • Dallas (3)
  • Detroit (4)
  • El Paso (6)
  • Houston (16)
  • Los Angeles (13)
  • Louisville (8)
  • Miami (12)
  • New England (12)
  • New Jersey (4)
  • New Orleans (5)
  • New York (17)
  • Omaha (15)
  • Phoenix (3)
  • Rocky Mountain (8)
  • San Antonio (3)
  • San Diego (2)
  • San Francisco (18)
  • Seattle (30)
  • Sede (20)
  • St. Louis (11)
  • Tampa (1)
  • Washington, DC (6)
Clear All Results
View Archived Press Releases
227 Results - Showing 171 to 180
PRESS RELEASE

Portland Veterinarian Sentenced for Diverting Controlled Substances for Personal Use

PORTLAND, Ore. — Dr. Brenda Brown-Carlson, a Portland veterinarian, was sentenced to 60 months of supervised probation on January 13, 2026, in Multnomah County Circuit Court as part of a plea agreement. Brown-Carlson admitted to diverting controlled substances for her personal use and replacing them with saline, impacting the treatment...
PRESS RELEASE

Schenectady Man Sentenced to 330 Months for Drug Trafficking and Firearm Crimes, and for Violating Supervised Release Conditions

ALBANY, NEW YORK – Jabree Jones, a.k.a. “Breezy,” age 33, of Schenectady, New York, was sentenced on January 9, 2026, to 300 months in prison for drug trafficking and firearms crimes, including a conspiracy to distribute and possess with intent to distribute fentanyl, cocaine, and methamphetamine, and possessing firearms in...
PRESS RELEASE

DEA Rocky Mountain Field Division Seizes Record Fentanyl Pills and Methamphetamine in 2025

DENVER – The DEA Rocky Mountain Field Division (RMFD) shattered records for fentanyl pill and methamphetamine seizures in 2025. Last year, approximately 8,729,000 fentanyl pills were seized in the RMFD – comprised of Colorado, Utah, Wyoming, and Montana – along with approximately 1,400 kilograms (nearly 3,100 lbs.) of methamphetamine. “These...
PRESS RELEASE

Laredo Pharmacist Pays Six Figures to Settle Controlled Substance Act Violations

HOUSTON – The owner of Martinez Pharmacy in Laredo has agreed to pay $750,000 to resolve allegations his pharmacy violated federal recordkeeping and dispensing requirements, announced Drug Enforcement Administration (DEA) Special Agent in Charge Miguel Madrigal of the San Antonio Division and U.S. Attorney Nicholas J. Ganjei. Antonio Martinez Jr...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

Two Rio Grande Valley Men Sentenced for Roles in Fentanyl Trafficking Operation

McALLEN, Texas – Two Rio Grande Valley men have been ordered to federal prison for their roles in a conspiracy to possess with intent to distribute fentanyl, announced Drug Enforcement Administration (DEA) Special Agent in Charge Brian Leardo of the Houston Division and U.S. Attorney Nicholas J. Ganjei. James Queen...
PRESS RELEASE

Repeat Offender Engaged in Fentanyl Trafficking in Spokane Sentenced to 204 Months in Federal Prison

SPOKANE, Wash.– United States District Judge Mary K. Dimke sentenced Kenneth H. Crause, age 55, to 204 months in federal prison after Crause pleaded guilty to Possession with Intent to Deliver 400 Grams or More of Fentanyl. Judge Dimke also ordered that, following his sentence, Crause be placed on a...
PRESS RELEASE

DEA’s Louisville Field Division Kept Nearly 89 Million Lethal Doses of Fentanyl out of Kentucky, Tennessee and West Virginia in 2025

LOUISVILLE, Ky. – Special agents and task force officers from the Drug Enforcement Administration’s Louisville Field Division seized 170,617 fentanyl-laced counterfeit pills and 177.76 kilograms of fentanyl powder since January 1, 2025. The DEA Laboratory estimates that these seizures represent nearly 89 million potentially deadly doses of fentanyl. Two milligrams...
PRESS RELEASE

Coordinated Federal-Local Law Enforcement Efforts Lead Surge in Arrests, Drug Seizures, and Federal Drug Trafficking Charges in San Francisco

SAN FRANCISCO – The U.S. Attorney’s Office and federal law enforcement partners announced today the results of a surge in federal drug enforcement measures in San Francisco over the past two months. Coordinated federal and local law enforcement efforts resulted in the seizure of over 1.04 kilograms of fentanyl—alone enough...
PRESS RELEASE

Spokane Physician Pays $120,000 to Resolve Allegations He Prescribed Controlled Substances Without Legitimate Medical Purpose

SPOKANE, Wash. –Dr. Duncan Lahtinen, a licensed physician, has paid $120,000.00 in penalties to resolve allegations that he wrote prescriptions for controlled substances that lacked legitimate medical purposes or were outside the usual course of his professional practice. Between 2017 and 2025, Dr. Lahtinen issued over 1,400 prescriptions for controlled...

Paginación

  • Primera página «
  • Anterior
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Current page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster